Evidence map›Paper›PMID 42488792›Full record

ArticleJAC-antimicrobial resistance2026

Performance of carbapenemase screening algorithms for detection of OXA-244-producing

Keziah N Keizer, Tom J Harryvan, Ianthe Maat, Saraa J Vainio, Anne L M Vlek, Damian C Melles, Rob J Rentenaar, Daphne E Groothuis, Jan A J W Kluytmans, Florine N J Frakking

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAC-antimicrobial resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Keziah N KeizerDepartment of Medical Microbiology, University Medical Centre Utrecht, PO Box 85500, 3805GA Utrecht, The Netherlands.
Tom J HarryvanDepartment of Medical Microbiology, University Medical Centre Utrecht, PO Box 85500, 3805GA Utrecht, The Netherlands.ORCID https://orcid.org/0000-0002-0386-8302
Ianthe MaatDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Saraa J VainioDepartment of Medical Microbiology and Immunology, St. Antonius Hospital, Nieuwegein, The  Netherlands.
Anne L M VlekDepartment of Microbiology and Immunology, Diakonessenhuis, Utrecht, The Netherlands.
Damian C MellesDepartment of Medical Microbiology and Medical Immunology, Meander Medical Centre, Amersfoort, The Netherlands.
Rob J RentenaarDepartment of Medical Microbiology, University Medical Centre Utrecht, PO Box 85500, 3805GA Utrecht, The Netherlands.
Daphne E GroothuisDepartment of Medical Microbiology, University Medical Centre Utrecht, PO Box 85500, 3805GA Utrecht, The Netherlands.
Jan A J W KluytmansDepartment of Medical Microbiology, University Medical Centre Utrecht, PO Box 85500, 3805GA Utrecht, The Netherlands.
Florine N J FrakkingDepartment of Medical Microbiology, University Medical Centre Utrecht, PO Box 85500, 3805GA Utrecht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: OXA-244-producing Methods: Twelve Results: All laboratories correctly detected no carbapenemase in three Discussion: Differences in CPE screening and confirmation protocols across five laboratories contributed to inconsistent detection of OXA-244-producing

Identifiers

PMID42488792
PMCPMC13390913

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.